Small Molecule Immuno-Oncology Compound Library

Kat.-Nr.L4800

Eine einzigartige Sammlung von 262 immunonkologischen niedermolekularen Substanzen, die zur Onkotherapie in Verbindung mit anderen Medikamenten eingesetzt werden.

96 well plates

Passen Sie Ihre Bibliothek an:

Zitiert von 322 Publikationen

Beschreibung & Vorteile

• A unique collection of 262 Immuno-Oncology small molecules for high throughput screening(HTS) and high content screening (HCS)
 
• Target includes PD-1/PD-L1, IDOCCRCXCRTLRHER2STAT3, etc.
 
• A useful tool for finding tumor therapeutic mechanism
 
• For studying human diseases, exploring the pathogenesis of diseases
such as cancer, and opening noval therapeutic ways
 
• Structurally diverse, medicinally active, and cell permeable
 
• Rich documentation with structure description, target information, IC50
 values and customer reviews
 
• NMR and HPLC validated to ensure high purity

 

Produktdetails

Formulierung 237 compounds pre-dissolved in 10mM DMSO, 13 compounds pre-dissolved in 10mM water, 11 compounds pre-dissolved in 2mM DMSO and 1 compound pre-dissolved in 2mM water
Behälter 96 Deep-Well-Platte mit Aluminiumfolie versiegelt
Stabilität 12 months -20°C in DMSO
24 months -80°C in DMSO
Versand Kühlakku oder Trockeneis

Fallstudien mit Selleck Compound-Bibliotheken

Small Molecule Immuno-Oncology Compound Library Zusammensetzung

HTS-Anlagenpartner

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania